Table 3.
Radionuclides and/or chelators for current clinical diagnostics of microbial infection.
| Metal and/or chelators | Non-metals | Targeted infection/diseases | Limitation | References |
|---|---|---|---|---|
| [99mTc]Tc-HMPAO/[99mTc]Tc-exametazine | Osteomyelitis and spondylodiscitis, FUO, joint prosthesis, soft tissue infection, cardiovascular system infections, vascular prostheses, peripheral musculoskeletal infections | Non-specific accumulation in kidneys and intestines released by [99mTc]Tc-exametazine | (23, 88–91) | |
| [111In]In-oxine | Joint prosthesis and other orthopedic prostheses, imaging kidneys, bladder, gallbladder, and intestines | Non-specific, higher radiation dose | (23, 92) | |
| [67Ga]Ga-citrate | Soft tissue infection, chronic osteomyelitis, opportunistic respiratory tract infections, FUO, tuberculosis, bone infection | Non-specific, higher radiation dose | (23, 89, 93–96) | |
| [68Ga]Ga-citrate | Osteomyelitis, intra-abdominal infection, tuberculosis, interstitial nephritis, bacteremia, lung infection | Non-specific | (96–99) | |
| [18F]fluorodeoxyglucose | FUO, prosthetic vascular graft, ED, VGI, osteomyelitis, prosthetic joint infection, and musculoskeletal infections, bacteremia, fungal infection, mycobacterial infection | Non-specific | (20–22, 74, 99–104) |